Mycofit
Mycofit (Mycophenolate Mofetil 500 mg) — for solid-organ transplant immunosuppression and refractory autoimmune disease. Specialist supervision required.
✓ Medicinskt granskad av Morgan Ellis — Apoteksforskare · 8 års erfarenhet · Senast granskad: maj 2026
Quick Answer
Mycofit — Mycophenolate Mofetil 500 mg (WHO-GMP certified manufacturer). Mycophenolate mofetil 500 mg for transplant rejection prevention and refractory autoimmune disease.
Vad du får med MedsBase:
- WHO-GMP-certifierad tillverkare
- Diskret förpackning i vanligt kuvert
- Världsvid leverans
- Betygsatt av 1 400+ kunder (läs recensioner)
📦 Reshipment Assurance: om din order inte har anlänt 20 arbetsdagar efter försändelse, skickar vi en ny utan extra kostnad. Läs policyn.
Varför beställa från MedsBase
Mycofit ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.
⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.
Immunosuppressants need ongoing specialist supervision (transplant, rheumatology, or haematology). Drug levels (cyclosporine, sirolimus, tacrolimus), FBC, LFTs, renal function, lipids, glucose, BP — all need regular monitoring. Infection surveillance is mandatory. Vaccination status must be optimised before starting; live vaccines contraindicated during therapy.
Long-term immunosuppression increases risks: opportunistic infections (PCP, CMV, EBV-driven PTLD), bacterial/fungal infection, reactivation of latent TB or HBV/HCV. Increased risk of skin cancer (especially squamous cell), lymphoproliferative disease, and other malignancies. Annual skin checks, regular cancer surveillance per guidelines.
Vanliga frågor
When is this used?
Mycophenolate mofetil 500 mg for transplant rejection prevention and refractory autoimmune disease. Always specialist-supervised — transplant, rheumatology, haematology, or oncology context.
Why is monitoring needed?
Therapeutic drug monitoring (cyclosporine, sirolimus, tacrolimus): trough levels target organ-protection without toxicity. Renal function: most are nephrotoxic. Lipids/glucose: metabolic effects. FBC: marrow suppression.
Läkemedelsinteraktioner?
Critical class — strong CYP3A4 substrates (calcineurin inhibitors, mTOR inhibitors). Many interactions: antifungals raise levels (often dramatically — even 5-10×), rifampicin drops levels (rejection risk), grapefruit raises levels. Any new medication should be checked first.
Vaccines?
Inactivated vaccines fine; live vaccines contraindicated during therapy. Optimise vaccinations BEFORE starting — pneumococcal, annual influenza, hepatitis B, varicella, MMR, HPV as appropriate.
Graviditet?
Mycophenolate is teratogenic — strict contraception. Cyclosporine, tacrolimus, azathioprine are used in pregnancy with specialist supervision. mTOR inhibitors generally avoided. Always discuss family planning with specialist.
Cancer screening?
Skin checks every 6-12 months (lifelong skin cancer risk). Cervical cytology more frequent. Lymph nodes — monitor for lymphoproliferative disease.
Infections?
Cotrimoxazole prophylaxis for PCP first 6-12 months post-transplant. CMV monitoring. TB screening before starting. Ongoing infection vigilance — fever needs prompt assessment.
Sun protection?
Daily broad-spectrum SPF 50+ from the day of transplant onwards. Annual dermatology review. Skin cancer is the most common post-transplant malignancy.
Vad händer om jag missar en dos?
Take when you remember if same day; if >12 hours late, skip and resume next dose. Do not double up. Consistent levels matter — discuss adherence with your transplant team.
Stopping?
Never stop without specialist guidance — risks acute rejection (transplant) or disease flare (autoimmune). Tapers happen over months, not days, and only when clinically appropriate.
Other Immunosuppressant & Cancer Medications
- Mycept — mycophenolate mofetil 250 mg — alternative MMF brand
- Mycofit — mycophenolate mofetil 500 mg
- Cyclophil ME — cyclosporine ME 25/50/100 mg
- Renodapt S — mycophenolate sodium 360 mg — enteric-coated
- Rapact — sirolimus 5/10 mg — mTOR inhibitor
More options in Anti Cancer Medication
Rangerade efter senaste ordervolym på MedsBase — vad andra kunder i denna kategori väljer.
| Styrka | 500 mg |
|---|---|
| Kvantitet | 30 Capsule/s, 60 Capsule/s, 90 Capsule/s |
| Farmaceutisk form | Kapsel/er |
| Tillverkare | Intas Pharma |
| Behandling | Anti Cancer |
| Generiskt märke | Mycophenolate Mofetil |
Mycofit
Frågor & svar
Mycofit
Relaterade produkter
Recensioner
Det finns inga recensioner än